Applications to the Fiscal Year 2015 (FY15) Reconstructive Transplant Research (RTR) program) are being solicited for the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the DHA RDA Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. This Program Announcement/Funding Opportunity and subsequent awards will be managed and executed by the Congressionally Directed Medical Research Programs (CDMRP) with strategic oversight from Joint Program Committee 8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP). To meet the intent of the FY15 RTR award mechanisms, applicants must address one or more of the Focus Areas listed below. â€˘ Immune system regulation â€˘ Improved access to reconstructive transplantation â€˘ Reconstructive transplantation rehabilitation â€˘ Graft surveillance â€“ Clinical monitoring â€˘ Psychosocial issues associated with VCA The RTR Concept Award (RTR CA) mechanism is being offered for the first time in FY15. A synopsis of all FY15 RTR Program Announcements/Funding Opportunities is available at http://cdmrp.army.mil/funding/pdf/15rtrpreftable.pdf The intent of the RTR CA is to support the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to RT. The Concept Award is not intended to support a logical progression of an already established research project but, instead, supports high-risk studies that have the potential to reveal entirely new avenues for investigation.